title: [Toxicity of intravesical gemcitabine in superficial bladder cancer treatment].
authors.affiliation: UGC de Urología. Hospital del SAS de Jerez de la Frontera. España..
authors.forename: P
authors.initials: P
authors.lastname: Beardo Villar
authors.affiliation: UGC de Urología. Hospital del SAS de Jerez de la Frontera. España..
authors.forename: R
authors.initials: R
authors.lastname: Gamaza Martínez
authors.affiliation: UGC de Farmacia. Hospital del SAS de Jerez de la Frontera. España.. rocio.gavira.sspa@juntadeandalucia.es.
authors.forename: R
authors.initials: R
authors.lastname: Gavira Moreno
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000150:complications* / Q000188:drug therapy; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000150:complications* / Q000188:drug therapy; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine